Jane Street’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$74.1M Sell
1,031,300
-481,900
-32% -$37.1M 0.01% 797
2025
Q4
$120M Sell
1,513,200
-419,600
-22% -$33.1M 0.02% 502
2025
Q3
$146M Sell
1,932,800
-2,200
-0.1% -$151K 0.02% 442
2025
Q2
$133M Buy
1,935,000
+872,300
+82% +$57.2M 0.03% 376
2025
Q1
$72M Sell
1,062,700
-316,700
-23% -$19M 0.02% 489
2024
Q4
$61.9M Sell
1,379,400
-1,137,300
-45% -$63.8M 0.01% 600
2024
Q3
$158M Sell
2,516,700
-502,700
-17% -$29.3M 0.03% 272
2024
Q2
$178M Buy
3,019,400
+2,169,500
+255% +$136M 0.04% 231
2024
Q1
$67.8M Sell
849,900
-600,000
-41% -$45.8M 0.01% 500
2023
Q4
$114M Buy
1,449,900
+456,600
+46% +$32.5M 0.03% 352
2023
Q3
$69.4M Sell
993,300
-921,500
-48% -$65.3M 0.02% 435
2023
Q2
$132M Sell
1,914,800
-168,100
-8% -$12M 0.04% 256
2023
Q1
$155M Buy
2,082,900
+959,400
+85% +$80.5M 0.06% 187
2022
Q4
$105M Sell
1,123,500
-492,200
-30% -$47.5M 0.05% 285
2022
Q3
$154M Sell
1,615,700
-434,300
-21% -$43M 0.07% 174
2022
Q2
$190M Buy
2,050,000
+866,600
+73% +$84.6M 0.08% 160
2022
Q1
$120M Sell
1,183,400
-1,153,400
-49% -$121M 0.04% 320
2021
Q4
$241M Sell
2,336,800
-399,500
-15% -$36.9M 0.08% 151
2021
Q3
$232M Buy
2,736,300
+1,420,000
+108% +$119M 0.08% 136
2021
Q2
$110M Buy
1,316,300
+92,200
+8% +$7.55M 0.04% 294
2021
Q1
$92.1M Sell
1,224,100
-17,400
-1% -$1.27M 0.05% 298
2020
Q4
$84.8M Sell
1,241,500
-349,500
-22% -$22.7M 0.04% 289
2020
Q3
$92.9M Buy
1,591,000
+739,000
+87% +$46M 0.06% 234
2020
Q2
$55.4M Sell
852,000
-64,600
-7% -$4.07M 0.04% 326
2020
Q1
$54.4M Buy
916,600
+701,100
+325% +$46.8M 0.05% 235
2019
Q4
$16M Sell
215,500
-1,100
-0.5% -$77.2K 0.02% 456
2019
Q3
$13.7M Sell
216,600
-126,600
-37% -$7.5M 0.02% 472
2019
Q2
$18.7M Sell
343,200
-172,100
-33% -$9.27M 0.03% 393
2019
Q1
$27.8M Buy
515,300
+306,902
+147% +$18.9M 0.05% 314
2018
Q4
$13.7M Buy
208,398
+94,398
+83% +$7.05M 0.03% 442
2018
Q3
$8.97M Sell
114,000
-23,300
-17% -$1.67M 0.02% 674
2018
Q2
$8.84M Buy
137,300
+69,000
+101% +$4.55M 0.02% 670
2018
Q1
$4.25M Sell
68,300
-54,700
-44% -$3.92M 0.01% 1102
2017
Q4
$8.92M Buy
123,000
+14,300
+13% +$1.04M 0.03% 555
2017
Q3
$8.84M Buy
108,700
+63,100
+138% +$4.99M 0.03% 573
2017
Q2
$3.67M Sell
45,600
-424,700
-90% -$33.5M 0.01% 976
2017
Q1
$36.9M Buy
470,300
+315,200
+203% +$25.2M 0.16% 110
2016
Q4
$12.2M Sell
155,100
-227,400
-59% -$18.4M 0.05% 288
2016
Q3
$34M Buy
382,500
+189,100
+98% +$17.8M 0.16% 115
2016
Q2
$18.5M Buy
193,400
+156,500
+424% +$15.6M 0.09% 205
2016
Q1
$3.83M Sell
36,900
-49,600
-57% -$4.82M 0.02% 706
2015
Q4
$8.46M Buy
86,500
+20,100
+30% +$1.97M 0.05% 315
2015
Q3
$6.41M Buy
66,400
+46,700
+237% +$4.91M 0.04% 372
2015
Q2
$2.07M Buy
+19,700
New +$2.01M 0.01% 987
2015
Q1
Sell
-5,500
Closed -$530K 3146
2014
Q4
$530K Buy
+5,500
New +$485K ﹤0.01% 1428

Other funds holding CVS

Jane Street's CVS Position: Q1 2026 in Review

Jane Street reduced its CVS Health (CVS) stake by 18% in Q1 2026, selling an estimated $1.3M and leaving 75,453 shares worth $5.42M. The position accounts for ﹤0.01% of the portfolio, ranked #3387.

Jane Street first reported a position in CVS in Q2 2013 and has held it in 50 quarters since. The position peaked at $169M in Q4 2024. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Jane Street held 75,453 shares of CVS Health worth $5.42M as of Q1 2026.
  • Jane Street sold 16,823 CVS Health shares in Q1 2026, an estimated $1.3M.
  • CVS Health made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #3387 holding.
  • Jane Street first reported a position in CVS Health in Q2 2013 and has held it in 50 quarters since.
  • Jane Street's CVS Health position peaked at $169M in Q4 2024.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.